Ladenburg Thalmann Financial Services’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $706K | Buy |
|
|||||
|
2019
Q3 | $308K | Sell |
|
|||||
|
2019
Q2 | $538K | Buy |
|
|||||
|
2019
Q1 | $531K | Buy |
|
|||||
|
2018
Q4 | $360K | Buy |
|
|||||
|
2018
Q3 | $441K | Sell |
|
|||||
|
2018
Q2 | $429K | Hold |
|
|||||
|
2018
Q1 | $429K | Buy |
|
|||||
|
2017
Q4 | $422K | Sell |
|
|||||
|
2017
Q3 | $552K | Buy |
|
|||||
|
2017
Q2 | $441K | Buy |
|
|||||
|
2017
Q1 | $279K | Buy |
|
|||||
|
2016
Q4 | $275K | Buy |
|
|||||
|
2016
Q3 | $227K | Buy |
|
|||||
|
2016
Q2 | $161K | Buy |
|
|||||
|
2016
Q1 | $191K | Sell |
|
|||||
|
2015
Q4 | $330K | Sell |
|
|||||
|
2015
Q3 | $448K | Sell |
|
|||||
|
2015
Q2 | $819K | Buy |
|
|||||
|
2015
Q1 | $567K | Buy |
|
|||||
|
2014
Q4 | $592K | Buy |
|
|||||
|
2014
Q3 | $387K | Sell |
|
|||||
|
2014
Q2 | $385K | Buy |
|
|||||
|
2014
Q1 | $371K | Sell |
|
|||||
|
2013
Q4 | $780K | Buy |
|
|||||
|
2013
Q3 | $286K | Sell |
|
|||||
|
2013
Q2 | $243K | Buy |
|